☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
LianBio
LianBio Entered into a Clinical Supply Agreement with AstraZeneca to Evaluate BBP-398 + Osimertinib for Non-Small Cell Lung Cancer...
July 13, 2023
LianBio Reports the NMPA Acceptance of NDA and Granted Priority Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy
April 24, 2023
PharmaShots' Key Highlights of Fourth Quarter 2020
January 14, 2021
PharmaShots Weekly Snapshot (November 16-20, 2020)
November 20, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
